Max Robotics — Global Service Robot Directory + US Certification

About

Koji Shiraishi is a leading Japanese urologist whose research focuses on improving outcomes in urological cancers, particularly bladder and prostate cancer. He has made significant contributions to clinical practice guidelines, notably as a key author of the Japanese Urological Association's "Clinical Practice Guidelines for Bladder Cancer 2019 edition," a seminal work that has garnered 37 citations and shapes national treatment standards. Shiraishi's work on quality of life after prostate cancer surgery is especially impactful; his 2023 study on sexual function following robot-assisted radical prostatectomy (RARP) challenges traditional assessment methods by questioning the adequacy of the IIEF questionnaire, earning 9 citations. He has also contributed to rare disease characterization, such as mucin-producing urothelial-type adenocarcinoma of the prostate, and addressed occupational safety in urology through a 15-year multi-institutional review of needlestick injuries. With over 50 publications, Shiraishi's research bridges clinical practice, surgical innovation, and patient-centered outcomes, making him a respected voice in urological oncology and a valuable resource for students and clinicians seeking evidence-based advancements in cancer care.